• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in

Blog

Featured post

Introducing Truveta Live Link

Truveta Live Link unites a life sciences organization’s proprietary data and continuously updated real-world clinical data from Truveta in a secure, integrated environment with expert determination included, enabling complete, continuous, regulatory-grade evidence that can replace costly and time-consuming trials and registries. 

Read more
Truveta Live Link announcement graphic featuring the Truveta logo and headline ‘Introducing Truveta Live Link,’ highlighting scientifically rigorous research and transforming proprietary data into real-world evidence.
Research
Data
Technology
News & events
Type 1 diabetes research with Truveta Data, including over 607k patient journeys and 1.4M inpatient encounters
Research

Type 1 diabetes: New opportunities for research with Truveta Live Link

  • Truveta staff
  • January 15, 2026
Truveta Live Link announcement graphic featuring the Truveta logo and headline ‘Introducing Truveta Live Link,’ highlighting scientifically rigorous research and transforming proprietary data into real-world evidence.
News

Introducing Truveta Live Link

  • Truveta News
  • January 13, 2026
First 90 days after stroke, new research from Bayer using Truveta Data
Research

The first 90 days after stroke: What real-world data show

  • Truveta staff
  • January 7, 2026
Truveta real-world evidence study examining delayed or absent first doses of measles, mumps, and rubella (MMR) vaccination, published in JAMA Network Open.
Featured researchResearch

Delayed or absent first dose of measles, mumps, and rubella vaccination

  • Truveta Research
  • January 2, 2026
Thumbnail graphic titled ‘Respiratory virus–associated hospitalizations: Trends through November 2025’ with Truveta logo and background featuring stacked respiratory virus hospitalization data peaks.
Research

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2025 

  • Truveta Research
  • December 11, 2025
Graphic with the Truveta logo and the headline ‘Rising use of GLP-1 medications among women with PCOS,’ set on a blue background with stylized ascending bar shapes representing increasing medication use.
Featured researchResearch

Rising use of GLP-1 medications among women with PCOS

  • Truveta Research
  • December 9, 2025
Truveta machine learning research graphic on enhancing BERT models with large language models for healthcare data applications, published on Zenodo
Research

Advancing biomedical AI: Enhancing BERT performance with LLM-generated annotations

  • Truveta staff
  • December 2, 2025
Thumbnail banner showing the Truveta logo and the headline ‘Cannabis and Thanksgiving’ with the subtitle ‘Exploring cannabis-related ED visits around Thanksgiving,’ over a blue background with stylized line-graph visuals.
Research

Rate of cannabis-related ED visits around Thanksgiving (2021–2024)

  • Truveta Research
  • November 25, 2025
Graphic titled “Truveta experts: Tracking HPV vaccination trends with real-world EHR data,” featuring the Truveta logo and a circular photo of Mantas Dmukauskas, PhD, labeled as Research Analyst at Truveta. The background is a blue-to-purple gradient with subtle bar-chart elements.
Research

Truveta experts: Tracking HPV vaccination trends with real-world EHR data

  • Truveta staff
  • November 24, 2025
« Previous 1 2 3 … 42 Next »

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.